Research and Markets (http://www.researchandmarkets.com/reports/c91915)has announced the addition of “United States ENT/Hearing Aid Devices Medical Equipment Industry Report: Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Hearing Implants and Hearing Aid Devices†to their offering.
United States ENT Devices Industry Report
Summary
This report is an essential source for in-depth information and data relating to the USA ENT Devices devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the ENT Devices in USA.
Scope
– The report provides sector information broken down into detailed categories and segments in country.
– Total revenues, products sold, end users, and average pricing.
– Market shares of all the key competitors.
– Key pipeline products that are set to shape the market, broken down by sector.
– Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
– Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
– Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
– Key mergers and acquisitions, partnerships, private equity investments and IPOs.
– Customer, hospitals and physicians data.
Reasons to buy
– Gain a strong understanding of the industry at a global level, with break downs for the country.
– Evaluate and compare the attractiveness of the market in the country.
– Identify growth segments and opportunities in each industry sector within the country.
– Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
– Analyze the competitiveness of the market in the country and identify hotspots.
– Develop strategies based on the latest product, brand, expansion and research and development news in the country.
– Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
– Identify and analyze the strengths and weaknesses of the industry incumbents in the country.
Contents:
1 Table Of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9
2 Introduction 12
2.1 What Is This Report About? 12
2.2 Definitions 12
2.2.1 ENT Devices 12
3 Healthcare Sector Review 14
3.1 Healthcare Expenditure 14
3.2 Healthcare Infrastructure 19
3.2.1 Healthcare Personnel Data 21
3.2.2 Healthcare Facilities Data 24
4 ENT Devices in United States 26
4.1 ENT Devices Overall Revenues (2000-2012) 26
4.2 ENT Devices Overall Volume (2000-2012) 32
4.3 ENT Devices Overall Company Share (2005-2006) 33
5 Hearing Aid Devices in United States 35
5.1 Hearing Aid Devices Overall Revenues (2000-2012) 35
5.1.1 Analog Hearing Aids Overall Revenues (2000-2012) 41
5.2 Hearing Aid Devices Overall Volume (2000-2012) 43
5.2.1 Digital Signal Processing Hearing Aids Overall Volume (2000-2012) 45
5.2.2 Analog Hearing Aids Overall Volume (2000-2012) 47
5.3 Hearing Aid Devices Average Price (2000-2012) 49
5.3.1 Analog Hearing Aids Average Price (2000-2012) 49
5.3.2 Digital Signal Processing Hearing Aids Average Price (2000-2012) 51
5.4 Hearing Aid Devices Distribution Share (2005-2006) 53
5.5 Hearing Aid Devices Company Share (2005-2006) 54
6 Hearing Implants in United States 55
6.1 Hearing Implants Overall Revenues (2000-2012) 55
6.1.1 Cochlear Implant Overall Revenues (2000-2012) 59
6.1.2 Bone Anchored Hearing Implants Overall Revenues (2000-2012) 61
6.2 Hearing Implants Overall Volume (2000-2012) 63
6.2.1 Cochlear Implant Overall Volume (2000-2012) 65
6.2.2 Bone Anchored Hearing Implants Overall Volume (2000-2012) 67
6.3 Hearing Implants Average Price (2000-2012) 69
6.3.1 Bone Anchored Hearing Implants Average Price (2000-2012) 69
6.3.2 Cochlear Implant Average Price (2000-2012) 71
6.4 Hearing Implants Distribution Share (2005-2006) 73
6.5 Hearing Implants Company Share (2005-2006) 74
7 Diagnostic Devices in United States 75
7.1 Diagnostic Devices Overall Revenues (2000-2012) 75
7.1.1 Audiometer Overall Revenues (2000-2012) 79
7.1.2 Otoscope Overall Revenues (2000-2012) 81
7.2 Diagnostic Devices Overall Volume (2000-2012) 83
7.2.1 Otoscope Overall Volume (2000-2012) 85
7.2.2 Audiometer Overall Volume (2000-2012) 87
7.3 Diagnostic Devices Average Price (2000-2012) 89
7.3.1 Otoscope Average Price (2000-2012) 89
7.3.2 Audiometer Average Price (2000-2012) 91
7.4 Diagnostic Devices Distribution Share (2005-2006) 93
7.5 Diagnostic Devices Company Share (2005-2006) 94
8 William Demant Holding A/S 95
8.1.1 Company Overview 95
8.1.2 Business Overview 95
8.1.3 Value Chain Analysis 98
8.1.4 SWOT Analysis 99
8.1.5 Financial and Operational Review 103
8.1.6 Locations And Subsidiaries 105
9 Phonak Holding AG 107
9.1.1 Phonak Holding AG Company Overview 107
9.1.2 Phonak Holding AG Business Overview 107
9.1.3 Value Chain Analysis 110
9.1.4 SWOT Analysis 111
9.1.5 Financial and Operational Review 114
9.1.6 Locations And Subsidiaries 116
10 GN ReSound A/S 120
10.1.1 GN ReSound A/S Company Overview 120
10.1.2 GN ReSound A/S Business Overview 120
10.1.3 Locations And Subsidiaries 122
11 Cochlear Limited 125
11.1.1 Cochlear Limited Company Overview 125
11.1.2 Cochlear Limited Business Overview 125
11.1.3 Value Chain Analysis 129
11.1.4 SWOT Analysis 130
11.1.5 Financial and Operational Review 133
11.1.6 Locations And Subsidiaries 134
12 Widex A/S 137
12.1.1 Widex A/S Company Overview 137
12.1.2 Widex A/S Business Overview 137
12.1.3 Locations And Subsidiaries 140
13 Regulation System 142
13.1 Medical Equipment Approval Process 142
13.1.1 Pre-market Approval Process 143
13.1.2 Intended use and Indications for use 143
13.1.3 Predicate Device 144
13.1.4 Safe and Effective 144
20.1.1 Other Category Devices 146
20.1.2 Post-Market Approval Process 147
25.1.1 Compliance and Enforcement 147
25.1.2 Registration Fee 148
25.1.3 Approval Time 148
26 Pricing and Reimbursement 149
26.1 Government Policies 149
30.1 Private Insurance 150
38.1 Diagnosis Related Groups (DRG) 151
39 Distribution Structure 152
39.1 Distribution Structure 152
40 APPENDIX 153
List of Tables
List of Figures
For more information visit http://www.researchandmarkets.com/reports/c91915
Source: Global Markets Direct
Research and Markets
Laura Wood
Senior Manager
press@researchandmarkets.com
Fax: +353 1 4100 980
